Predictors of overall survival
| Predictor | Univariate HR (95% CI) | p Value |
| Median age | 1.04 (0.98 to 1.05) | 0.45 |
| Time to T2 progression (months) | 0.94 (0.88 to 1.0) | 0.06 |
| Gender (male vs female) | 0.57 (0.3 to 1.09) | 0.09 |
| Aetiology of liver disease | 1.87 (0.78 to 4.48) | 0.16 |
| Treatment versus observation status | 1.53 (0.77 to 3.03) | 0.22 |
| Tumour size (cm) | 1.31 (0.42 to 4.09) | 0.65 |
| MELD | 0.99 (0.93 to 1.06) | 0.99 |
| Child score (stage A vs C) | 0.73 (0.31 to 1.73) | 0.75 |
| Child score (stage B vs C) | 0.88 (0.38 to 2.08) | |
| AFP | 1.00 (1.00 to 1.00) | 0.18 |
| Transplant evaluation | 1.73 (0.09 to 3.28) | 0.10 |
| Receiving a transplant | 0.13 (0.03 to 0.44) | 0.001* |
Transplantation is the only covariate that predicts survival in the multivariate model, demonstrating that receiving a transplant decreases mortality.
No other variables were significant on univariate or multivariate models.
*Indicates p value is significant for univariate and multivariate models.
AFP, alpha-fetoprotein; MELD, model for end-stage liver disease.